Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Arch Environ Contam Toxicol ; 51(2): 237-43, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16783621

ABSTRACT

The pharmaceutical estrogen 17alpha-ethinylestradiol (EE2) and the anabolic androgen 17beta-trenbolone (Tb) can interfere with the endocrine and reproductive systems of fish. The potency of these chemicals in zebrafish (Danio rerio) and Japanese medaka (Oryzias latipes) was assessed using the core end points vitellogenin (Vtg) concentration at 38 days post-hatch and sex ratio and gonad morphology at 60 days post-hatch. Vtg concentrations were measured in fish whole-body homogenate samples using enzyme-linked immunosorbent assay. Increased Vtg concentration and feminization of fish after exposure to 10 ng/L EE2, as well as masculinization after exposure to 50 ng/L of Tb, were observed in zebrafish. Intersex was observed in medaka exposed to EE2. A decrease in Vtg production after Tb exposure (50 ng/L) was measured in both zebrafish and medaka. Analyses of gonad morphology revealed increased testicular area and sperm percentage in Tb-exposed zebrafish, whereas increased sperm percentage was measured in Tb-exposed medaka. The higher sensitivity of zebrafish compared with medaka to both EE2 and Tb was revealed in the study.


Subject(s)
Ethinyl Estradiol/toxicity , Oryzias/physiology , Trenbolone Acetate/toxicity , Zebrafish/physiology , Animals , Female , Male , Oocytes/drug effects , Oocytes/growth & development , Sex Ratio , Spermatozoa/drug effects , Spermatozoa/growth & development , Testis/drug effects , Testis/growth & development , Vitellogenins/analysis
2.
J Ethnopharmacol ; 73(1-2): 95-100, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11025144

ABSTRACT

This study was performed on anaesthetized male Wistar rats that received a continuous intravenous perfusion during 1.25 h of an aqueous extract of aerial parts of Urtica dioica L. (Urticaceae) at a low dose of 4 mg/kg/h or at a high dose of 24 mg/kg/h, or furosemide (control diuretic) at a dose of 2 mg/kg/h. As compared with a control period in each rat, the arterial blood pressure was reduced proportionally to the dose of the perfusion of the plant extract (15 and 38%, P<0.001, respectively). These effects were accompanied by a correlative increase of diuresis (11 and 84%, P<0. 001, respectively) and natriuresis (28 and 143%, P<0.001, respectively). In the rats perfused by furosemide, the arterial blood pressure was reduced by 28% (P<0.001). The diuresis and natriuresis were also increased proportionally in this case (85 and 155%, P<0.001, respectively). Nevertheless, the hypotensive action of U. dioica was reversible during the recovery periods in about 1 h with the lower dose of the plant extract and furosemide, while the effect of the higher dose was persistent, indicating a possible toxic effect. In conclusion, the results demonstrate an acute hypotensive action of U. dioica that indicates a direct effect on the cardiovascular system. Moreover, diuretic and natriuretic effects were also observed, suggesting an action on the renal function. Finally, the plant extract seems to have a toxic effect at the higher dose.


Subject(s)
Antihypertensive Agents/pharmacology , Blood Pressure/drug effects , Diuretics/pharmacology , Magnoliopsida , Natriuresis/drug effects , Plant Extracts/pharmacology , Analysis of Variance , Animals , Antihypertensive Agents/administration & dosage , Diuresis/drug effects , Diuretics/administration & dosage , Dose-Response Relationship, Drug , Furosemide/pharmacology , Infusions, Intravenous , Male , Plant Extracts/administration & dosage , Plant Extracts/isolation & purification , Rats , Rats, Wistar
3.
Brain Dev ; 15(5): 346-55, 1993.
Article in English | MEDLINE | ID: mdl-7506498

ABSTRACT

Eighteen patients, 16 boys and 2 girls, aged 5-14 years, with subacute sclerosing panencephalitis (SSPE) were treated with oral isoprinosine (100 mg/kg/day) and intraventricular alpha-interferon 2b (Intron A, Schering Corp.), starting at 500,000 U twice a week and later increasing to 3 million U biweekly. Minimal follow-up of living patients is 12 months; maximal 40 months. On the basis of the Neurological Disability Index (NDI) scores and staging, 8 have treatment-induced remissions (3 improved, 5 arrested), 4 are worse and 6 died. This 44% (8/18) rate of remission/improvement compares well with the 9% (1/11) remission in historical controls in the same institution (p = < 0.05) and 5% spontaneous remission in the literature. Combined oral isoprinosine-intraventricular alpha-interferon appears to be an effective treatment for SSPE.


Subject(s)
Inosine Pranobex/therapeutic use , Interferon-alpha/therapeutic use , Subacute Sclerosing Panencephalitis/drug therapy , Administration, Oral , Adolescent , Child , Child, Preschool , Drug Therapy, Combination , Electroencephalography , Female , Humans , Injections, Intraventricular , Inosine Pranobex/administration & dosage , Interferon alpha-2 , Interferon-alpha/administration & dosage , Magnetic Resonance Imaging , Male , Recombinant Proteins , Subacute Sclerosing Panencephalitis/diagnostic imaging , Subacute Sclerosing Panencephalitis/pathology , Tomography, X-Ray Computed
SELECTION OF CITATIONS
SEARCH DETAIL
...